Open AccessNewer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes
Author(s) -
J.Y. Yang,
A.M. Moon,
H. Kim,
V. Pate,
A.S. Barritt,
M.J. Crowley,
J.B. Buse,
T. Stürmer,
A.-S. Alexopoulos
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/43yc-q543
Subject(s) - type 2 diabetes , diabetes mellitus , medicine , cirrhosis , rosiglitazone , endocrinology